microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells

62Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

microRNAs (miRNAs), small non-coding RNAs, have emerged as key regulators of a large number of genes. The present study aimed to explore novel biological functions of miR-330 in the human prostate cancer cell lines DU145 and PC3. We confirmed that miR-330 was downregulated and inversely correlated with specificity protein 1 (Sp1) expression. Overexpression of miR-330 by transfection of a chemically synthesized miR-330 mimic induced a reduction in expression levels of the Sp1 protein, accompanied by significant suppression of cellular migration and invasion capability. In addition, the Sp1-knockdown experiments presented similar phenomena. Finally, the luciferase reporter assay validated Sp1 as the direct target of miR-330. These findings indicate that miR-330 acts as an anti-metastatic miRNA in prostate cancer.

Cite

CITATION STYLE

APA

Mao, Y., Chen, H., Lin, Y., Xu, X., Hu, Z., Zhu, Y., … Xie, L. (2013). microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells. Oncology Reports, 30(1), 327–333. https://doi.org/10.3892/or.2013.2452

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free